- Exicure Announces Phase 1b Poster Presentation at The Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting – BioSpace
- Bristol Myer Squibb advances cancer immunotherapy in Europe – The Science Board
- Immunotherapy combo halts rare, stage 4 sarcoma in teen – EurekAlert
- Patients with soft-tissue cancer show rapid and complete response to novel combination of immunotherapy – News-Medical.Net
